Rational Combination of Parvovirus H1 With CTLA-4 and PD-1 Checkpoint Inhibitors Dampens the Tumor Induced Immune Silencing

The recent therapeutic success of immune checkpoint inhibitors in the treatment of advanced melanoma highlights the potential of cancer immunotherapy. Oncolytic virus-based therapies may further improve the outcome of these cancer patients. A human ex vivo melanoma model was used to investigate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Goepfert, Katrin, Dinsart, Christiane, Rommelaere, Jean, Foerster, Friedrich, Moehler, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546938/
https://www.ncbi.nlm.nih.gov/pubmed/31192129
http://dx.doi.org/10.3389/fonc.2019.00425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546938/
https://www.ncbi.nlm.nih.gov/pubmed/31192129
http://dx.doi.org/10.3389/fonc.2019.00425

Ejemplares similares